Cy-Chaine is at the forefront of lab-based meat production technology, designed to meet the growing demands of the cultivated meat market. By providing an innovative and efficient solution, Cy-Chaine enables producers to overcome the limitations of traditional methods, driving the industry forward.

In June 2023, a significant milestone was achieved with U.S. approval for lab-grown meat. California startups began selling cultivated chicken, signaling the advent of a new era in food production. The cultivated meat market has since evolved into a multi-billion-dollar industry, expanding into upscale restaurants and increasing its production capabilities to meet the rising consumer demand for sustainable and ethical alternatives.

Addressing Industry Challenges

One of the primary challenges facing the cultivated meat industry is that current lab meat production methods still rely heavily on Fetal Bovine Serum (FBS), raising significant sustainability and ethical concerns. Cy-Chaine is designed to tackle these challenges through its minimal formulation, optimized for cell endurance and growth. This FBS-free solution offers a complete substrate that enhances cell growth and viability without needing specialized cell engineering.

The Cy-Chaine Solution

Cy-Chaine minimal formulation is optimized for cell endurance and growth, offering a complete substrate that enhances cell growth and viability without the need for specialized cell engineering or reliance on animal-derived components. Its formulation improves cell growth efficiency, leading to higher yields and faster production cycles. Additionally, Cy-Chaine lowers production costs, making lab-based meat a more accessible option for producers and consumers alike.